This topic contains a solution. Click here to go to the answer

Author Question: If two small perfectly competitive firms merge, the merged firm will be: a. a price-taker. b. a ... (Read 67 times)

formula1

  • Hero Member
  • *****
  • Posts: 666
If two small perfectly competitive firms merge, the merged firm will be:
 a. a price-taker.
  b. a market leader.
  c. a price-discriminator.
  d. an oligopoly.

Question 2

Which of the following characteristics apply to both monopoly and monopolistic competition?
 a. Marginal revenue exceeds marginal cost at equilibrium.
 b. Average revenue exceeds both marginal cost and marginal revenue at equilibrium.
  c. Marginal revenue exceeds average revenue at equilibrium.
 d. Marginal revenue and marginal cost are equal and exceed price at equilibrium.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

blazinlyss

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

A

Answer to Question 2

b




formula1

  • Member
  • Posts: 666
Reply 2 on: Jun 30, 2018
YES! Correct, THANKS for helping me on my review


patma1981

  • Member
  • Posts: 292
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library